Analysis: Alzheimer’s drug trial breakthrough boost for Roche, Eli Lilly

Biogen and Eisai report a landmark result for an experimental drug Almost all Alzheimer’s trials have previously failed Roche and Eli Lilly drugs target the same protein as Eisai’s compound Biogen Stocks of all four drugmakers soar on news LONDON, Sept 28 (Reuters) – The results of a key trial of an Alzheimer’s drug on … Read more

Novartis to prioritise U.S. market, unfazed by drug pricing pushback

The logo of Swiss pharmaceutical company Novartis is seen at the company’s plant in the northern Swiss town of Stein October 23, 2017. REUTERS/Arnd Wiegmann/File photo Sign up now for FREE unlimited access to Reuters.com Record ZURICH, Sept 22 (Reuters) – Swiss pharmaceutical giant Novartis (NOVN.S) he said he would make growth in the United … Read more

Investors mixed as Porsche seeks price tag of up to $75 bln

Sign up now for FREE unlimited access to Reuters.com Record Volkswagen shares little changed, Porsche SE up 3.5% Porsche AG will be listed at a valuation of 70-75 billion euros The listing comes amid turmoil in European markets Cornerstone investors pledged 40% of share offering BERLIN, Sept 19 (Reuters) – Shares of Volkswagen (VOWG_p.DE) hovered … Read more

Analysis: Price hikes test Inditex’s ability to stay in fashion

Sign up now for FREE unlimited access to Reuters.com Record Initial prices at Zara rise 12.2% in the year to July: UBS Inditex says it will raise prices again in the second half Analysts urge caution amid signs of slowing apparel demand MADRID, Sept 15 (Reuters) – Zara owner Inditex’s strong first half results show … Read more

Global cargo market sags as softer economy points to gloomy Christmas

Sign up now for FREE unlimited access to Reuters.com Record SYDNEY/BENGALURU, Sept 16 (Reuters) – World trade indicators such as FedEx and Cathay Pacific Airways (0293.HK) have clouded the year-end holiday shopping season: The trade slowdown they’re seeing points to weaker-than-expected consumer demand, not a holiday bonanza. The bleak outlook comes as consumers around the … Read more

WHO ‘strongly advises against’ use of two COVID treatments

A woman holds a small bottle labeled with a “COVID-19 coronavirus vaccine” sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic Sign up now for FREE unlimited access to Reuters.com Record LONDON, Sept 15 (Reuters) – The World Health Organization (WHO) no longer recommends two COVID-19 antibody therapies, on the … Read more

Porsche IPO to comprise 911 million shares in nod to its most famous model

Sign up now for FREE unlimited access to Reuters.com Record Volkswagen supervisory board to meet on Sunday: sources Stock prospectus expected on Monday: sources Book construction will start early next week HAMBURG/FRANKFURT/LONDON, September 15 (Reuters) – Volkswagen’s (VOWG_p.DE) The supervisory board will meet on Sunday to move forward with the IPO of its Porsche brand, … Read more

European stocks fend of rate risks, yen droops again

European stocks rebound after two days of falls Fed looms over broader markets; risk of 100bp increase next week China real estate stocks buoyed by hopes of official help The risk of intervention keeps the dollar below the barrier of 145 yen LONDON, Sept 15 (Reuters) – Stock markets were sluggish and the dollar and … Read more

Analysis: European governments defy market volatility with green bond bonanza

Wind turbines of the Mozura wind farm are seen in Ulcinj, Montenegro, June 18, 2020. REUTERS/Stevo Vasiljevic/File Photo Sign up now for FREE unlimited access to Reuters.com Record Sept 15 (Reuters) – Euro zone governments have raised 15 billion euros ($15 billion) of green bonds in the past two weeks, lifting volumes above a year … Read more

Morning Bid: Terminal diagnosis? | Reuters

A trader stands below a trading floor screen showing the Dow Jones Industrial Average on the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., 13 September 2022. REUTERS/Andrew Kelly Sign up now for FREE unlimited access to Reuters.com Record A look at the day ahead in the US and world markets from … Read more